Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Stem cell therapy for pediatric dilated cardiomyopathy.

Selem SM, Kaushal S, Hare JM.

Curr Cardiol Rep. 2013 Jun;15(6):369. doi: 10.1007/s11886-013-0369-z. Review.

2.

Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients?

Garbern JC, Gauvreau K, Blume ED, Singh TP.

Circ Heart Fail. 2016 Jan;9(1):e002328. doi: 10.1161/CIRCHEARTFAILURE.115.002328. Epub 2015 Dec 23.

3.

Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy.

Singh TP, Sleeper LA, Lipshultz S, Cinar A, Canter C, Webber SA, Bernstein D, Pahl E, Alvarez JA, Wilkinson JD, Towbin JA, Colan SD.

Circ Heart Fail. 2009 Nov;2(6):591-8. doi: 10.1161/CIRCHEARTFAILURE.108.839001. Epub 2009 Sep 28.

4.

Use of stem cells in heart failure treatment: where we stand and where we are going.

Sánchez LA, Guerrero-Beltrán CE, Cordero-Reyes AM, García-Rivas G, Torre-Amione G.

Methodist Debakey Cardiovasc J. 2013 Oct-Dec;9(4):195-200. Review.

5.

Clinical experience with Berlin Heart Excor in pediatric patients in Argentina: 1373 days of cardiac support.

Moreno GE, Charroqui A, Pilán ML, Magliola RH, Krynski MP, Althabe M, Landry LM, Sciuccati G, Villa A, Vogelfang H.

Pediatr Cardiol. 2011 Jun;32(5):652-8. doi: 10.1007/s00246-011-9949-0. Epub 2011 Mar 20.

PMID:
21424518
6.

Outcomes and risk factors for heart transplantation in children with end-stage cardiomyopathy†.

Alsoufi B, Kanter K, McCracken C, Kogon B, Vincent R, Mahle W, Deshpande S.

Eur J Cardiothorac Surg. 2016 Jan;49(1):85-92. doi: 10.1093/ejcts/ezv067. Epub 2015 Feb 26.

PMID:
25724907
7.

Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.

Castelli G, Fornaro A, Ciaccheri M, Dolara A, Troiani V, Tomberli B, Olivotto I, Gensini GF.

Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.

8.

Outcomes of children following a first hospitalization for dilated cardiomyopathy.

Hollander SA, Bernstein D, Yeh J, Dao D, Sun HY, Rosenthal D.

Circ Heart Fail. 2012 Jul 1;5(4):437-43. doi: 10.1161/CIRCHEARTFAILURE.111.964510. Epub 2012 May 8.

9.

Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Everitt MD, Sleeper LA, Lu M, Canter CE, Pahl E, Wilkinson JD, Addonizio LJ, Towbin JA, Rossano J, Singh RK, Lamour J, Webber SA, Colan SD, Margossian R, Kantor PF, Jefferies JL, Lipshultz SE; Pediatric Cardiomyopathy Registry Investigators..

J Am Coll Cardiol. 2014 Apr 15;63(14):1405-13. doi: 10.1016/j.jacc.2013.11.059. Epub 2014 Feb 19.

10.

The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, Cox GF, Canter CE, Hsu DT, Webber SA, Lipshultz SE.

Heart Fail Clin. 2010 Oct;6(4):401-13, vii. doi: 10.1016/j.hfc.2010.05.002. Review.

11.

Current management of pediatric dilated cardiomyopathy.

Silva JN, Canter CE.

Curr Opin Cardiol. 2010 Mar;25(2):80-7. doi: 10.1097/HCO.0b013e328335b220. Review.

PMID:
20019605
12.

Cardiomyopathy and heart transplantation in children.

Morrow WR.

Curr Opin Cardiol. 2000 Jul;15(4):216-23. Review.

PMID:
11139084
13.

Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE.

JAMA. 2006 Oct 18;296(15):1867-76.

PMID:
17047217
14.

Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.

Rupp S, Apitz C, Tholen L, Latus H, Ostermayer SH, Schmidt D, Bauer J, Schranz D.

Cardiol Young. 2015 Oct;25(7):1300-5. doi: 10.1017/S1047951114002406. Epub 2014 Dec 12.

PMID:
25498517
15.

Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy.

Rupp S, Bauer J, Tonn T, Schächinger V, Dimmeler S, Zeiher AM, Schranz D.

Pediatr Transplant. 2009 Aug;13(5):620-3. doi: 10.1111/j.1399-3046.2008.01024.x. Epub 2009 Nov 26.

PMID:
19067928
16.

The incidence of pediatric cardiomyopathy in two regions of the United States.

Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD.

N Engl J Med. 2003 Apr 24;348(17):1647-55.

17.

From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG).

Kapusta L, Zucker N, Frenckel G, Medalion B, Ben Gal T, Birk E, Mandel H, Nasser N, Morgenstern S, Zuckermann A, Lefeber DJ, de Brouwer A, Wevers RA, Lorber A, Morava E.

Heart Fail Rev. 2013 Mar;18(2):187-96. doi: 10.1007/s10741-012-9302-6.

18.

Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry).

Harmon WG, Sleeper LA, Cuniberti L, Messere J, Colan SD, Orav EJ, Towbin JA, Wilkinson JD, Lipshultz SE.

Am J Cardiol. 2009 Jul 15;104(2):281-6. doi: 10.1016/j.amjcard.2009.03.033. Epub 2009 Jun 3.

19.

[Usefulness of intracoronary therapy with progenitor cells in patients with dilated cardiomyopathy: Bridge or alternative to heart transplantation?].

Rivas J, Menéndez JJ, Arrieta R, Alves J, Romero MP, García-Guereta L, Álvarez-Doforno R, Parrón M, González A, Ruza F, Gutiérrez-Larraya F.

An Pediatr (Barc). 2011 Apr;74(4):218-25. doi: 10.1016/j.anpedi.2011.02.013. Epub 2011 Mar 12. Spanish.

20.

Pediatric Dilated Cardiomyopathy Patients Do Not Meet Traditional Cardiac Resynchronization Criteria.

Schiller O, Dham N, Greene EA, Heath DM, Alexander ME, Berul CI.

J Cardiovasc Electrophysiol. 2015 Aug;26(8):885-9. doi: 10.1111/jce.12690. Epub 2015 May 25.

PMID:
25884372

Supplemental Content

Support Center